That IS great news : ).
Thank you kn0way!
As of the final investment decision notice on February 17 [see here] what ‘was next’ for the Wesfarmers Covalent project was just those environmental approvals:
.... “The necessary government and regulatory approvals have either been secured or are underway.Development of the integrated project remains subject to the Western Australian Environmental Protection Authority's assessment of the Kwinana refinery and the issuance of a Ministerial Statement to allow works to commence.
Following receipt of all relevant approvals, construction of the mine, concentrator and refinery are expected to commence in the first half of FY2022, with purchase of long lead time items commencing in late FY2021.
The first production of lithium hydroxide is expected in the second half of the 2024 calendar year. Wesfarmers’ share of capital expenditure for the development of the project is estimated at approximately $950 million1 and will be funded using existing cash and debt facilities.....”
Your link says the approval recommendations are now in the hands of Amber-Jade Sanderson, the state Environment Minister.... “who will make a decision following a two-week public appeal period, which was opened on Monday.”
.... and it says ..... “In its greenhouse gas management plan, the joint venture partners said the refinery was expected to have the lowest initial scope one and scope two emissions intensity for a spodumene refinery in the world.”
So final approval seems very much ‘just a technicality’ ?
..And that anticipated $950 million spend still leaves a lot in the ~$18 billion kitty?
By a curious coincidence today was also the day IGO received $889 million from Regis for its’ 30% share of Tropicana ... which means it can now proceed to the final stage of making its’ partnership with Tianqi official.
Cheers
- Forums
- ASX - By Stock
- WES
- WES - what's next?
WES - what's next?, page-9
-
- There are more pages in this discussion • 58 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WES (ASX) to my watchlist
|
|||||
Last
$70.01 |
Change
0.010(0.01%) |
Mkt cap ! $79.10B |
Open | High | Low | Value | Volume |
$70.17 | $70.44 | $69.68 | $28.43M | 406.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
22 | 838 | $69.99 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$70.01 | 924 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 622 | 69.950 |
5 | 464 | 69.940 |
7 | 422 | 69.930 |
6 | 2369 | 69.920 |
5 | 386 | 69.910 |
Price($) | Vol. | No. |
---|---|---|
69.980 | 321 | 5 |
69.990 | 228 | 4 |
70.000 | 5433 | 23 |
70.010 | 1236 | 14 |
70.020 | 301 | 5 |
Last trade - 12.11pm 16/07/2024 (20 minute delay) ? |
Featured News
WES (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online